Internal Medicine, Nephrology · McAllen, TX
NPI
1598027930
Since 2012
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1901 S 1st St Ste 600
McAllen, TX, 78503
Phone (956) 631-6136
Groups this clinician bills Medicare through
Medicare paid, 2024
$133K
990 services
Medicare patients, 2024
261
Average age 71
Drug cost, 2024
$1.4M
2,178 prescriptions
Company payments, 2025
$1,800
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Liliana E Rios Rojas was code 90960 (esrd related services (not dialysis)), 252 times for 48 patients. In total Liliana E Rios Rojas billed 990 services in 17 codes, and Medicare paid $133K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-11-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90960 ESRD Related Services (not dialysis) | Office | 252 | 48 | $279.58 | $70K |
| 99233 Hospital E&M - Subsequent | Facility | 191 | 91 | $96.02 | $18K |
| 99215 Office E&M - Established | Office | 125 | 77 | $132.90 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 100 | 68 | $13.59 | $1,359 |
| 99232 Hospital E&M - Subsequent | Facility | 73 | 42 | $61.18 | $4,466 |
| 99222 Hospital E&M - Initial | Facility | 39 | 37 | $81.82 | $3,191 |
| 90961 ESRD Related Services (not dialysis) | Office | 30 | 19 | $239.71 | $7,191 |
| 90935 Hemodialysis | Facility | 28 | 21 | $54.84 | $1,535 |
| 99214 Office E&M - Established | Office | 17 | 17 | $100.98 | $1,717 |
| 99205 Office E&M - New | Office | 11 | 11 | $166.18 | $1,828 |
By year: 2022 $200K for 1,395 services; 2023 $154K for 1,090 services; 2024 $133K for 990 services.
Medicare prescription drug claims, 2024
In 2024, the drug Liliana E Rios Rojas prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 199 prescriptions and refills. In total Liliana E Rios Rojas wrote 2,178 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 199 | 254 | 57 | $136K |
| Veltassa Patiromer Calcium Sorbitex | 161 | 236 | 48 | $233K |
| Auryxia Ferric Citrate | 152 | 304 | 43 | $472K |
| Sevelamer Carbonate Generic | 144 | 272 | 47 | $29K |
| Hydralazine Hcl Generic | 132 | 212 | 38 | $785 |
| Amlodipine Besylate Generic | 118 | 179 | 33 | $432 |
| Bumetanide Generic | 113 | 193 | 27 | $2,861 |
| Losartan Potassium Generic | 89 | 163 | 28 | $476 |
| Lisinopril Generic | 83 | 141 | 25 | $372 |
| Febuxostat Generic | 78 | 95 | 22 | $5,157 |
| Torsemide Generic | 71 | 127 | 24 | $732 |
| Velphoro Sucroferric Oxyhydroxide | 70 | 84 | 16 | $272K |
| Midodrine Hcl Generic | 55 | 88 | 21 | $1,804 |
| Carvedilol Generic | 53 | 108 | 23 | $301 |
| Nifedipine Er Nifedipine | 50 | 106 | 19 | $1,174 |
Brand drugs: 686 claims; generic drugs: 1,492 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Liliana E Rios Rojas $1,800 ($1,800 in general payments such as food, travel and fees) from 11 companies. The largest payer was Vifor Pharma, Inc. with $774.
| Company | Payments | Amount |
|---|---|---|
| Vifor Pharma, Inc. | 31 | $774 |
| Travere Therapeutics, Inc. TVTX | 6 | $190 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $165 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $143 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $124 |
| Lilly USA, LLC LLY | 1 | $117 |
| Novo Nordisk Inc NVO | 1 | $108 |
| Fresenius USA Marketing, Inc. | 3 | $64.34 |
| Amgen Inc. AMGN | 3 | $48.68 |
| Dexcom, Inc. DXCM | 2 | $44.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.